Showing results (91-100 of 123) with videos related to
Sort By:
Pageof 13
Molecular Cancer Therapeutics|July 5, 2021
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive CholangiocarcinomaKeiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2023
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal AdenocarcinomaTadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2018
Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression ProfilesTomomi Egawa-Takata, Kiyoshi Yoshino, Kosuke Hiramatsu, et al.Cancer Research|October 19, 2017
SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell CarcinomaTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.Elife|April 2, 2020
GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 AbDaiki Kato, Tomonori Yaguchi, Takashi Iwata, et al.Lung Cancer (Amsterdam, Netherlands)|April 9, 2008
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelinKota Iwahori, Tadashi Osaki, Satoshi Serada, et al.Cancer Research|December 1, 2017
LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid UptakeKosuke Hiramatsu, Satoshi Serada, Takayuki Enomoto, et al.Rheumatology (Oxford, England)|August 31, 2014
Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenonLingli Yang, Minoru Fujimoto, Hiroyuki Murota, et al.Cancer Science|November 11, 2025
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential TherapyNaoki Ikenaga, Tsuyoshi Takahashi, Koji Tanaka, et al.Cancer Science|June 12, 2021
CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancerMayu Shiomi, Shinya Matsuzaki, Satoshi Serada, et al.Pageof 13